文献速递乳腺外科

乳腺血管肉瘤是否需要淋巴结分期?

Does Angiosarcoma of the Breast Need Nodal Staging?
PubMed 文献 · J Am Coll Surg · 2022-01-01

基于美国国家癌症数据库2004—2017年991例非转移性乳腺血管肉瘤手术患者,30%接受区域淋巴结评估,其中5.0%淋巴结阳性。淋巴结阳性患者总生存显著更差,校正后风险比3.20(95%CI 1.75–5.86,p<0.001)。

要点

  • 非转移性乳腺血管肉瘤区域淋巴结阳性率约5.0%。
  • 淋巴结阳性与更差的总生存独立相关。
  • 需前瞻性研究评估前哨淋巴结活检效能。

核心结论

  • 非转移性乳腺血管肉瘤淋巴结阳性率5%,处于考虑评估的常见阈值,并识别生存差的患者。

研究设计与样本

  • 回顾性队列研究,使用美国国家癌症数据库2004—2017年非转移性乳腺血管肉瘤手术切除患者991例。

主要发现

  • 298例(30%)接受病理区域淋巴结评估,其中15例(5.0%)淋巴结阳性。
  • 淋巴结阳性患者生存显著差于区域淋巴结阴性患者。
  • 校正患者、肿瘤和治疗因素后,淋巴结阳性对比未行淋巴结评估的总生存风险比3.20(95%CI 1.75–5.86,p<0.001)。

临床怎么用

  • 对非转移性乳腺血管肉瘤可考虑区域淋巴结评估以识别高危患者。
  • 前哨淋巴结活检的效能尚需前瞻性研究确定。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Breast angiosarcoma is a rare malignancy classically associated with hematogenous metastases. We sought to determine the prevalence of pathologic nodal involvement in patients with nonmetastatic, resected breast angiosarcoma and its association with overall survival. STUDY DESIGN: The National Cancer Database was used to identify patients with nonmetastatic angiosarcoma of the breast who underwent surgical resection from 2004 to 2017. The prevalence of regional lymph node operation and nodal positivity was calculated. The Kaplan-Meier method was used to evaluate overall survival among node-positive and node-negative patients. Cox proportional hazard modeling was used to evaluate the adjusted association of nodal positivity with overall survival. RESULTS: We included 991 patients with angiosarcoma. The median age was 69 years (interquartile range 57 to 78), and the cohort was 99% female. A total of 298 patients (30%) had pathologic regional nodal evaluation. Of those, 15 (5.0%) had positive regional lymph nodes. Node-positive patients had significantly worse survival than patients with negative regional lymph nodes. After adjusting for patient, tumor, and treatment factors, a positive regional lymph node was associated with worse overall survival compared with patients with no nodal evaluation (hazard ratio 3.20; 95% CI 1.75 to 5.86; p < 0.001). CONCLUSIONS: Patients with nonmetastatic angiosarcoma of the breast have a 5% regional lymph node positivity rate, which is at a common threshold to consider evaluation, and identifies patients with poor survival. A prospective study to determine performance characteristics of sentinel lymph node biopsy is warranted.

来源:J Am Coll Surg,查看原文。版权归原作者所有。

引用

  1. Herb J, Maduekwe UN, Goel N, et al. Does Angiosarcoma of the Breast Need Nodal Staging? J Am Coll Surg. 2022. PMID: 35426390. doi:10.1097/XCS.0000000000000131

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。